Management flagged the importance of mitigating new tariffs, navigating the loss of exclusivity for major products, and sustaining growth from its expanding medicine pipeline. Management’s ...

When investing in dividend stocks, paying attention to the right things is essential. A high yield can be attractive, but the ...

The investment over the next eight years could be the largest ever industry-academic agreement of its kind in the U.S., the ...

Disc Medicine, Inc. announced significant advancements ... efforts for bitopertin as well as development of the rest of our pipeline. We expect data from ongoing trials of DISC-0974, the Phase ...

Announce initial clinical data from Cohort 1 in the Phase 1/2 trial of PM359 for p47 phox CGD in 2025. The initial readout ...

Two new drugs, one featured in JAMA, are moving through the regulatory gauntlet. One for smokers. The other for obese ...